Literature DB >> 20574448

Covalent histone modifications--miswritten, misinterpreted and mis-erased in human cancers.

Ping Chi1, C David Allis, Gang Greg Wang.   

Abstract

Post-translational modification of histones provides an important regulatory platform for processes such as gene transcription and DNA damage repair. It has become increasingly apparent that the misregulation of histone modification, which is caused by the deregulation of factors that mediate the modification installation, removal and/or interpretation, actively contributes to human cancer. In this Review, we summarize recent advances in understanding the interpretation of certain histone methylations by plant homeodomain finger-containing proteins, and how misreading, miswriting and mis-erasing of histone methylation marks can be associated with oncogenesis and progression. These observations provide us with a greater mechanistic understanding of epigenetic alterations in human cancers and might also help direct new therapeutic interventions in the future.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20574448      PMCID: PMC3262678          DOI: 10.1038/nrc2876

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN: 1474-175X            Impact factor:   60.716


  117 in total

1.  The language of covalent histone modifications.

Authors:  B D Strahl; C D Allis
Journal:  Nature       Date:  2000-01-06       Impact factor: 49.962

2.  Wnt/wingless signaling requires BCL9/legless-mediated recruitment of pygopus to the nuclear beta-catenin-TCF complex.

Authors:  Thomas Kramps; Oliver Peter; Erich Brunner; Denise Nellen; Barbara Froesch; Sandipan Chatterjee; Maximilien Murone; Stephanie Züllig; Konrad Basler
Journal:  Cell       Date:  2002-04-05       Impact factor: 41.582

Review 3.  Translating the histone code.

Authors:  T Jenuwein; C D Allis
Journal:  Science       Date:  2001-08-10       Impact factor: 47.728

4.  ALL-1 is a histone methyltransferase that assembles a supercomplex of proteins involved in transcriptional regulation.

Authors:  Tatsuya Nakamura; Toshiki Mori; Shinichiro Tada; Wladyslaw Krajewski; Tanya Rozovskaia; Richard Wassell; Garrett Dubois; Alexander Mazo; Carlo M Croce; Eli Canaani
Journal:  Mol Cell       Date:  2002-11       Impact factor: 17.970

5.  MLL targets SET domain methyltransferase activity to Hox gene promoters.

Authors:  Thomas A Milne; Scott D Briggs; Hugh W Brock; Mary Ellen Martin; Denise Gibbs; C David Allis; Jay L Hess
Journal:  Mol Cell       Date:  2002-11       Impact factor: 17.970

6.  EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells.

Authors:  Celina G Kleer; Qi Cao; Sooryanarayana Varambally; Ronglai Shen; Ichiro Ota; Scott A Tomlins; Debashis Ghosh; Richard G A B Sewalt; Arie P Otte; Daniel F Hayes; Michael S Sabel; Donna Livant; Stephen J Weiss; Mark A Rubin; Arul M Chinnaiyan
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-19       Impact factor: 11.205

Review 7.  Nuclear pore proteins and cancer.

Authors:  Songli Xu; Maureen A Powers
Journal:  Semin Cell Dev Biol       Date:  2009-03-18       Impact factor: 7.727

Review 8.  The molecular biology of mixed lineage leukemia.

Authors:  Robert K Slany
Journal:  Haematologica       Date:  2009-06-16       Impact factor: 9.941

9.  p29ING4 and p28ING5 bind to p53 and p300, and enhance p53 activity.

Authors:  Masayuki Shiseki; Makoto Nagashima; Remy M Pedeux; Mariko Kitahama-Shiseki; Koh Miura; Shu Okamura; Hitoshi Onogi; Yuichiro Higashimoto; Ettore Appella; Jun Yokota; Curtis C Harris
Journal:  Cancer Res       Date:  2003-05-15       Impact factor: 12.701

10.  Haematopoietic malignancies caused by dysregulation of a chromatin-binding PHD finger.

Authors:  Gang G Wang; Jikui Song; Zhanxin Wang; Holger L Dormann; Fabio Casadio; Haitao Li; Jun-Li Luo; Dinshaw J Patel; C David Allis
Journal:  Nature       Date:  2009-06-11       Impact factor: 49.962

View more
  481 in total

Review 1.  Epigenetic protein families: a new frontier for drug discovery.

Authors:  Cheryl H Arrowsmith; Chas Bountra; Paul V Fish; Kevin Lee; Matthieu Schapira
Journal:  Nat Rev Drug Discov       Date:  2012-04-13       Impact factor: 84.694

Review 2.  Targeting the epigenome with bioactive food components for cancer prevention.

Authors:  Thomas Prates Ong; Fernando Salvador Moreno; Sharon Ann Ross
Journal:  J Nutrigenet Nutrigenomics       Date:  2012-02-22

3.  DNA methylation: superior or subordinate in the epigenetic hierarchy?

Authors:  Bilian Jin; Yajun Li; Keith D Robertson
Journal:  Genes Cancer       Date:  2011-06

4.  The decade of the epigenomes?

Authors:  Joost H A Martens; Hendrik G Stunnenberg; Colin Logie
Journal:  Genes Cancer       Date:  2011-06

5.  Double-strand break-induced transcriptional silencing is associated with loss of tri-methylation at H3K4.

Authors:  Doris M Seiler; Jacques Rouquette; Volker J Schmid; Hilmar Strickfaden; Christian Ottmann; Guido A Drexler; Belinda Mazurek; Christoph Greubel; Volker Hable; Günther Dollinger; Thomas Cremer; Anna A Friedl
Journal:  Chromosome Res       Date:  2011-10-11       Impact factor: 5.239

6.  The impact of solubility and electrostatics on fibril formation by the H3 and H4 histones.

Authors:  Traci B Topping; Lisa M Gloss
Journal:  Protein Sci       Date:  2011-11-09       Impact factor: 6.725

Review 7.  Chromatin landscape: methylation beyond transcription.

Authors:  Joshua C Black; Johnathan R Whetstine
Journal:  Epigenetics       Date:  2011-01-01       Impact factor: 4.528

8.  Cigarette smoke induces distinct histone modifications in lung cells: implications for the pathogenesis of COPD and lung cancer.

Authors:  Isaac K Sundar; Michael Z Nevid; Alan E Friedman; Irfan Rahman
Journal:  J Proteome Res       Date:  2013-12-13       Impact factor: 4.466

9.  KDM2B promotes pancreatic cancer via Polycomb-dependent and -independent transcriptional programs.

Authors:  Alexandros Tzatsos; Polina Paskaleva; Francesco Ferrari; Vikram Deshpande; Svetlana Stoykova; Gianmarco Contino; Kwok-Kin Wong; Fei Lan; Patrick Trojer; Peter J Park; Nabeel Bardeesy
Journal:  J Clin Invest       Date:  2013-01-16       Impact factor: 14.808

Review 10.  Nuclear organization mediates cancer-compromised genetic and epigenetic control.

Authors:  Sayyed K Zaidi; Andrew J Fritz; Kirsten M Tracy; Jonathan A Gordon; Coralee E Tye; Joseph Boyd; Andre J Van Wijnen; Jeffrey A Nickerson; Antony N Imbalzano; Jane B Lian; Janet L Stein; Gary S Stein
Journal:  Adv Biol Regul       Date:  2018-05-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.